| scholarly article | Q13442814 |
| P50 | author | Anna K. Nowak | Q40897391 |
| Zacariah E Labby | Q97552077 | ||
| P2093 | author name string | James J Dignam | |
| Samuel G Armato | |||
| Hedy L Kindler | |||
| Arman Hasani | |||
| P2860 | cites work | The European mesothelioma epidemic | Q24650064 |
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| Reporting results of cancer treatment | Q29620070 | ||
| Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials. | Q33379936 | ||
| Advances in malignant mesothelioma | Q34459139 | ||
| Changing trends in US mesothelioma incidence | Q35501138 | ||
| Measures of response: RECIST, WHO, and new alternatives | Q36531372 | ||
| Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival | Q37360623 | ||
| Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors | Q39605793 | ||
| A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters | Q43108072 | ||
| Current state and future directions of pleural mesothelioma imaging | Q46864742 | ||
| Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. | Q51996240 | ||
| Modeling of mesothelioma growth demonstrates weaknesses of current response criteria. | Q53547668 | ||
| CT, RECIST, and malignant pleural mesothelioma. | Q53581720 | ||
| Receiver operating characteristic rating analysis. Generalization to the population of readers and patients with the jackknife method | Q57732027 | ||
| Modified RECIST criteria for assessment of response in malignant pleural mesothelioma | Q61628213 | ||
| Variance-component modeling in the analysis of receiver operating characteristic index estimates | Q73597372 | ||
| Measuring response in a post-RECIST world: from black and white to shades of grey | Q83190877 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1728-1734 | |
| P577 | publication date | 2012-11-01 | |
| P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
| P1476 | title | Optimization of response classification criteria for patients with malignant pleural mesothelioma | |
| P478 | volume | 7 |
| Q28603645 | An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol |
| Q41008161 | Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial |
| Q36702389 | Disease volumes as a marker for patient response in malignant pleural mesothelioma. |
| Q38994262 | Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group |
| Q36685687 | Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma. |
| Q90056572 | Objective response rate assessment in oncology: Current situation and future expectations |
| Q93380858 | Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma |
Search more.